Eudaimonia Partners, LLC Biocryst Pharmaceuticals Inc Transaction History

Eudaimonia Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$9.5 - $17.24 $85,500 - $155,160	-9,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $95,810 - $176,930	-13,000 Reduced 59.09%	9,000 $92,000
Q4 2020 Feb 18, 2021	SELL	$3.37 - $8.61 $197,482 - $504,545	-58,600 Reduced 72.7%	22,000 $164,000
Q3 2020 Nov 23, 2020	BUY	$3.43 - $5.53 $276,458 - $445,718	80,600 New	80,600 $277,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.